Sudden cardiac death in long-term follow-up in patients treated with primary percutaneous coronary intervention.
暂无分享,去创建一个
L. Savic | M. Ašanin | R. Lasica | S. Stanković | G. Krljanac | I. Mrdovic | D. Simic
[1] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[2] Yoshio Kobayashi,et al. Factors that predict ventricular arrhythmias in the late phase after acute myocardial infarction , 2021, ESC heart failure.
[3] M. Ueda,et al. Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease: A prospective propensity score–matched analysis from the Nippon Storm Study , 2021, Heart rhythm O2.
[4] M. Pfeffer,et al. Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database. , 2020, European heart journal. Acute cardiovascular care.
[5] M. Pfeffer,et al. Predictors of sudden cardiac death in high‐risk patients following a myocardial infarction , 2020, European journal of heart failure.
[6] M. Pfeffer,et al. Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non‐sudden cardiac death in myocardial infarction survivors with heart failure , 2019, European journal of heart failure.
[7] Z. Siudak,et al. Radial Approach Expertise and Clinical Outcomes of Percutanous Coronary Interventions Performed Using Femoral Approach , 2019, Journal of clinical medicine.
[8] I. Kallikazaros,et al. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study , 2019, European heart journal.
[9] D. Atar,et al. Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. , 2018, International journal of cardiology.
[10] J. Chandrasekhar,et al. Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI , 2016, Open Heart.
[11] Andrea Mazzanti,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.
[12] C. Hassager,et al. Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention – is it necessary? , 2015, European heart journal. Acute cardiovascular care.
[13] W. Hua,et al. Incidence and predictors of sudden cardiac death in patients with reduced left ventricular ejection fraction after myocardial infarction in an era of revascularisation , 2014, Heart.
[14] I. Mrdović,et al. Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register , 2014, European heart journal. Acute cardiovascular care.
[15] G. Hindricks,et al. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? , 2013, European heart journal.
[16] E. Vittinghoff,et al. Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease. , 2011, Archives of internal medicine.
[17] N. Hagiwara,et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry , 2008, Heart.
[18] Robert S Sheldon,et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. , 2007, Journal of the American College of Cardiology.
[19] J. Ottervanger,et al. Mortality in patients with left ventricular ejection fraction =30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction. , 2007, The American journal of cardiology.
[20] V. Fuster,et al. Primary prophylaxis with the implantable cardioverter-defibrillator: The need for improved risk stratification , 2005 .